S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Current Liabilities
â‚©83.7B
CAGR 3-Years
22%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Total Current Liabilities
â‚©4T
CAGR 3-Years
96%
CAGR 5-Years
45%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Total Current Liabilities
â‚©64.7B
CAGR 3-Years
61%
CAGR 5-Years
45%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Current Liabilities
â‚©3.9B
CAGR 3-Years
8%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Current Liabilities
â‚©37.1B
CAGR 3-Years
48%
CAGR 5-Years
19%
CAGR 10-Years
43%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Current Liabilities
â‚©53.9B
CAGR 3-Years
193%
CAGR 5-Years
80%
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S

See Also

What is ST Pharm Co Ltd's Total Current Liabilities?
Total Current Liabilities
83.7B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Total Current Liabilities amounts to 83.7B KRW.

What is ST Pharm Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
50%

Over the last year, the Total Current Liabilities growth was -46%. The average annual Total Current Liabilities growth rates for ST Pharm Co Ltd have been 22% over the past three years , 50% over the past five years .

Back to Top